Book
"Doing Business in the US: Medical Devices and Pharmaceuticals"
![]() |
The United States is the biggest market for medical devices and pharmaceuticals. |
Executive Summary
With nearly 1 million physicians and 6,000 hospitals treating 310 million consumers, the US healthcare market is the largest in the world. This, coupled with the fact that the US spends more of its GDP on healthcare than any other country, leads to some of the highest pricing in the world as well.
So, if all of this is true, why are high quality medical products developed by non-US companies marketed successfully elsewhere but not in the United States? Why wouldn’t all companies participate in this treasure trove of opportunity?
The answer is that often non-US companies avoid this lucrative market because they perceive it as too risky – too costly to enter, too complex to manage, and a complex FDA approval process. What most people don’t realize is that many wrong perceptions of the US market exist. For example, there are a number of similarities between the EU and FDA approval requirements. Importantly, the risks that do exist can be managed in highly effective ways.
This helpful book published by TCG describes how the rewards for participating in the US can far outweigh the risks. It provides international companies an overview of the US market, and demystifies the process for achieving success. It outlines a step-wise protocol for launching your new medical device or pharmaceutical product. It provides a roadmap for addressing everything from conducting a cost effective US market assessment, to FDA planning and clearance, and to the formation of your own US subsidiary. It will answer many of your questions as you consider how best to capture a share of the largest market in the world.
If you have a medical device or drug being sold in Europe, or any other international market, and have data from solid clinical trials, the time to evaluate your US market opportunity is now.
TCG understands the unique dynamics of the US environment and how to find the right position for an innovative product. We handle everything from conducting market opportunity assessments and finding the right partners to setting up direct sales and distribution channels. We have developed and manage a number of cost-efficient operating subsidiaries of international companies.
If you would like a free copy of this informative book, please send your name, company name, address and email to Dr. Reinhard Merz in Heidelberg, Germany (reinhard.merz@tcgmedtech.com) or Ms. Diane Conolly in Durham, NC, USA (diane.conolly@tcgmedtech.com).
© TCG, 2010


